Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders.

Gianelli U, Vener C, Raviele PR, Savi F, Somalvico F, Calori R, Iurlo A, Radaelli F, Fermo E, Bucciarelli P, Bori S, Coggi G, Deliliers GL.

Am J Clin Pathol. 2007 Dec;128(6):966-73.

2.

Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor.

Steurer M, Zoller H, Augustin F, Fong D, Heiss S, Strasser-Weippl K, Gastl G, Tzankov A.

Hum Pathol. 2007 Jul;38(7):1057-64. Epub 2007 Apr 18.

PMID:
17442379
3.

Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms.

Boiocchi L, Vener C, Savi F, Bonoldi E, Moro A, Fracchiolla NS, Iurlo A, Deliliers GL, Coggi G, Bosari S, Gianelli U.

J Clin Pathol. 2011 Mar;64(3):226-31. doi: 10.1136/jcp.2010.083386. Epub 2011 Jan 8.

PMID:
21217153
4.

Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.

Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.

Eur J Haematol. 2004 Jun;72(6):410-5.

PMID:
15128419
5.

Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.

Marković O, Marisavljević D, Cemerikić V, Vidović A, Perunicić M, Todorović M, Elezović I, Colović M.

Med Oncol. 2008;25(4):451-7. doi: 10.1007/s12032-008-9066-y. Epub 2008 May 1.

PMID:
18449811
6.

Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.

Kvasnicka HM, Thiele J.

Histol Histopathol. 2004 Oct;19(4):1245-60. Review.

PMID:
15375769
7.

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.

Boveri E, Passamonti F, Rumi E, Pietra D, Elena C, Arcaini L, Pascutto C, Castello A, Cazzola M, Magrini U, Lazzarino M.

Br J Haematol. 2008 Jan;140(2):162-8. Epub 2007 Nov 19.

PMID:
18028479
8.

Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.

Medinger M, Skoda R, Gratwohl A, Theocharides A, Buser A, Heim D, Dirnhofer S, Tichelli A, Tzankov A.

Br J Haematol. 2009 Jul;146(2):150-7. doi: 10.1111/j.1365-2141.2009.07726.x. Epub 2009 May 19.

PMID:
19466975
9.
11.

[Study on the role of angiogenesis and related factors in leukemias].

Zhang Y, Gu J, Wang M, Ma L, Wang XL, He B, Sun M.

Zhonghua Xue Ye Xue Za Zhi. 2005 Mar;26(3):175-8. Chinese.

PMID:
15946533
12.

Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.

Ponzoni M, Savage DG, Ferreri AJ, Pruneri G, Viale G, Servida P, Bertolini F, Orazi A.

Mod Pathol. 2004 Dec;17(12):1513-20.

13.

Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).

Wróbel T, Mazur G, Surowiak P, Wolowiec D, Jelen M, Kuliczkowsky K.

Pathol Oncol Res. 2003;9(3):170-3. Epub 2003 Oct 7.

15.

Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.

Kuzu I, Beksac M, Arat M, Celebi H, Elhan AH, Erekul S.

Leuk Lymphoma. 2004 Jun;45(6):1185-90.

PMID:
15359999
16.

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.

Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.

Leuk Lymphoma. 2006 Mar;47(3):451-60.

PMID:
16396768
17.

[Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia].

Zhang L, Wang HJ, Li HQ, Yang DL, Yan ZS, Wu YH, Zhou K, Chu YL, Chen HS, Zhang FK.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):528-31. Chinese.

PMID:
18078128
18.

Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders.

Bock O, Tessema M, Serinsöz E, von Wasielewski R, Büsche G, Kreipe H.

Leuk Res. 2004 Nov;28(11):1145-51.

PMID:
15380337
19.

Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity.

Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J.

Am J Pathol. 2000 Jul;157(1):15-9. Erratum in: Am J Pathol 2000 Aug;157(2):690.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk